Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
Conditions
- HER2-positive Breast Cancer
- Male Breast Cancer
- Stage IV Breast Cancer
Interventions
- BIOLOGICAL: HER-2/neu peptide vaccine
- DRUG: cyclophosphamide
- BIOLOGICAL: ex vivo-expanded HER2-specific T cells
- OTHER: laboratory biomarker analysis
- OTHER: flow cytometry
- OTHER: immunoenzyme technique
Sponsor
University of Washington
Collaborators